Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
49 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

PTIX — Protagenic Therapeutics, Inc. Dilution Risk Tracker

Track PTIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTIX — Get alerts when the score changes →

As of August 28, 2026, Protagenic Therapeutics, Inc. (PTIX) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Protagenic Therapeutics, Inc. has a market capitalization of $982.9K, 1.81M shares outstanding. Stored dilution-related fields include 81.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊Float Risk
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 40%
🔄 Reverse Split model est. 65%
• 50-day avg $0.65 below $1 exchange minimum
• 6 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (6mo)
🔁 Convertible Conversion model 15%
• Convertible debt present: 12.9% potential dilution
🔔 Track PTIX — Get forecast alerts →

Market Data

Market Cap$982.9K
Shares Outstanding1.81M
FloatN/A
Cash$1.78M
Debt$4.00M
Short InterestN/A

Institutional Holdings

4.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PTIX for full holder detail →

Short Interest

Short Interest13.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2023-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PTIX Dilution Snapshot

Protagenic Therapeutics, Inc. (PTIX) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PTIX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTIX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note